Emergent BioSolutions EBS
NYSE EBS
$6.28 -0.08 (-1.26%)
As of: Oct 20, 2026 · 3:48 PM EDT

Emergent BioSolutions (EBS) Non-Current Debt (2010 - 2026)

Updated

Emergent BioSolutions (EBS) posted Non-Current Debt of $581.8 million for Q2 2026, down 12.9% from $667.8 million a year earlier but up 1.4% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Non-Current Debt (2010 - 2026) Analysis & Trends

At the end of FY2025, Emergent BioSolutions' Non-Current Debt came in at $572.1 million, down 13.8% from FY2024.

  • Annual Non-Current Debt shows a five-year compound annual growth rate of -7.4% (FY2020 to FY2025).
  • In prior years, Emergent BioSolutions' Non-Current Debt was $663.7 million in FY2024 (+48.6%), $446.5 million in FY2023 (-0.4%), $448.5 million in FY2022 (-44.6%) and $809.4 million in FY2021 (-3.8%).
  • Quarterly Non-Current Debt has run from a low of $446.5 million in Q4 2023 to a high of $1.03 billion in Q3 2022 over five years.
  • On a year-over-year basis, Non-Current Debt has declined in each of the last three quarters, with growth averaging 19.3% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Debt in the past five years was Q2 2025, with growth of 49.4%; the weakest was Q3 2023, with a decline of 56.6%.
  • According to Business Quant data, Non-Current Debt for the three prior quarters was $573.6 million (Q1 2026), $572.1 million (Q4 2025) and $663.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,148.26 Bn 1,116.85 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 624.74 Bn 543.27 Bn 17.26 Bn 37.34 Bn
3 AbbVie 509.56 Bn 482.67 Bn 12.70 Bn 62.48 Bn
4 Merck 366.23 Bn 320.60 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.81 Bn 261.80 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 262.30 Bn 235.98 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.17 Bn 191.57 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.42 Bn 168.61 Bn 6.22 Bn 23.83 Bn
9 Pfizer 172.08 Bn 118.73 Bn 10.94 Bn 60.50 Bn
10 Emergent BioSolutions 325.60 Mn -425.30 Mn 137.20 Mn 581.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 581.80 Mn
Mar 31, 2026 573.60 Mn
Dec 31, 2025 572.10 Mn
Sep 30, 2025 663.10 Mn
Jun 30, 2025 667.80 Mn
Mar 31, 2025 665.70 Mn
Dec 31, 2024 663.70 Mn
Sep 30, 2024 661.80 Mn
Jun 30, 2024 447.00 Mn
Mar 31, 2024 446.70 Mn
Dec 31, 2023 446.50 Mn
Sep 30, 2023 448.20 Mn
Jun 30, 2023 448.00 Mn
Mar 31, 2023 447.70 Mn
Dec 31, 2022 448.50 Mn
Sep 30, 2022 1.03 Bn
Jun 30, 2022 793.60 Mn
Mar 31, 2022 801.50 Mn
Dec 31, 2021 809.40 Mn
Sep 30, 2021 817.30 Mn
API Access

Emergent BioSolutions Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=EBS&period=max&api_key=YOUR_API_KEY